Dariusz Jemielniak's ABMI - academic body mass index - proposal pokes fun at the seemingly endless metricisation of present-day academia.
Accent Therapeutics, a clinical-stage biopharmaceutical company pioneering a new class of small molecule precision cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback